Table 1 Characteristics of Cases and Controls by 1:5 matching on propensity score for comorbidities and bisphosphonate therapy
Variables | Cases (n = 94) | Controls (n = 461) | P Value |
|---|---|---|---|
Comorbidities, no (%) | |||
Diabetes mellitus | 34 (36.2) | 147 (31.9) | 0.420 |
Arterial hypertension | 63 (67.0) | 311 (67.5) | 0.934 |
Hyperlipidemia | 20 (21.3) | 102 (22.1) | 0.856 |
Coronary heart disease | 34 (36.2) | 158 (34.3) | 0.725 |
Myocardial infarction | 1 (1.1) | 8 (1.7) | 0.639 |
Cardiac dysrhythmia | 18 (19.2) | 71 (15.4) | 0.367 |
PAODa | 3 (3.2) | 21 (4.6) | 0.554 |
Kidney dysfunction | 2 (2.1) | 4 (0.9) | 0.282 |
Stroke/TIAb | 4 (4.3) | 26 (5.6) | 0.589 |
Dementia | 11 (11.7) | 60 (13.0) | 0.728 |
Parkinson’s disease | 11 (11.7) | 44 (9.5) | 0.523 |
COPDc | 24 (25.5) | 113 (24.5) | 0.834 |
Osteoporosis | 25 (26.6) | 133 (28.9) | 0.659 |
Arthritis | 33 (35.1) | 145 (31.5) | 0.489 |
Bisphosphonate therapy, no (%) | 26 (27.7) | 123 (26.7) | 0.855 |
Propensity score, mean points (SD) | 0.17 (0.04) | 0.16 (0.03) | |
(Min, Max) | (0.10, 0.43) | (0.08, 0.31) | |
Age, mean years (SD) | 74.0 (2.6) | 69.5 (3.6) | <0.001* |
Sex, no. (%) | 0.995 | ||
Male | 33 (35.1) | 162 (35.1) | |
Female | 61 (64.9) | 299 (64.9) | |